Search filters

List of works by Wyndham H. Wilson

A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype.

scientific article

A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications

scientific article published on 01 April 2020

A multiprotein supercomplex controlling oncogenic signalling in lymphoma

scientific article published in Nature

A new prognostic score for AIDS-related lymphomas in the rituximab-era

scientific article

A novel role for IL-22R1 as a driver of inflammation

scientific article

A pilot study of CTLA-4 blockade after cancer vaccine failure in patients with advanced malignancy

article

A pilot study of the value of 18F-fluoro-deoxy-thymidine PET/CT in predicting viable lymphoma in residual 18F-FDG avid masses after completion of therapy

scientific article published on October 2014

A prospective study of mediastinal gray-zone lymphoma

scientific article

ABVD plus rituximab ABVD alone for advanced stage, high-risk classical Hodgkin lymphoma: a randomized phase 2 study

scientific article published on 06 September 2018

ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes.

scientific article

Acquired immunodeficiency syndrome-related malignancies in the era of highly active antiretroviral therapy

scientific article published on July 2006

Activation of CD44, a receptor for extracellular matrix components, protects chronic lymphocytic leukemia cells from spontaneous and drug induced apoptosis through MCL-1 ⬇️

scientific article published on June 8, 2011

Aggressive natural killer cell leukemia/lymphoma: case report, use of telesynergy and review of the literature

scientific article published in June 2004

Albumin enhanced morphometric image analysis in CLL.

scientific article published on January 2004

Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease ⬇️

scientific article published on November 1, 1997

Angioimmunoblastic T cell lymphoma: pathobiological insights and clinical implications

scientific article published on July 2007

Angioimmunoblastic T-cell lymphoma: immune modulation as a therapeutic strategy

scientific article published on 01 March 2007

Appropriate management of molecular subtypes of diffuse large B-cell lymphoma

scientific article published on April 2014

Association of lymphomatoid granulomatosis with Epstein-Barr viral infection of B lymphocytes and response to interferon-alpha 2b

scientific article published on 01 June 1996

Autoreactive, cytotoxic T lymphocytes specific for peptides derived from normal B-cell differentiation antigens in healthy individuals and patients with B-cell malignancies

scientific article published on February 2004

B-cell lymphoma in a patient with complete interferon gamma receptor 1 deficiency

scientific article published on 26 June 2013

B-cell recovery following rituximab-based therapy is associated with perturbations in stromal derived factor-1 and granulocyte homeostasis

scientific article published on 17 February 2005

BCL-6 and rituximab in diffuse large B-cell lymphoma: where are we?

scientific article published on 01 January 2007

Baseline mutational patterns and sustained MRD negativity in patients with high-risk smoldering myeloma

article

Bcl‐2 level as a biomarker for 13q14 deletion in CLL ⬇️

scientific article published on May 14, 2013

Bendamustine and rituximab in relapsed and refractory hairy cell leukemia

scientific article

Beyond RCHOP: A Blueprint for Diffuse Large B Cell Lymphoma Research

scientific article

Biology and management of rare primary extranodal T-cell lymphomas.

scientific article published on January 2010

Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation

scientific article

Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics

scientific article published on 12 August 2012

CNS involvement in primary mediastinal large B-cell lymphoma

scientific article

Cardiac involvement with lymphoma: a review of the literature

scientific article

Central nervous system involvement in AIDS-related lymphomas

scientific article published on 07 April 2016

Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States

scientific article

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

scientific article

Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma

scientific article published on 20 August 2018

Circulating serum free light chains as predictive markers of AIDS-related lymphoma

scientific article

Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study

scientific article published on April 2015

Cladribine with immediate rituximab for the treatment of patients with variant hairy cell leukemia

scientific article

Clinical Reversal of Multidrug Resistance

scientific article published on 01 January 1996

Clinical reversal of multidrug resistance

scientific article published on 01 January 1996

Coexisting and clonally identical classic hodgkin lymphoma and nodular lymphocyte predominant hodgkin lymphoma.

scientific article

Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: results of a phase II study

scientific article published on 01 May 2000

Combined normal donor and CLL: Single tube ZAP‐70 analysis ⬇️

scientific article published on October 26, 2011

Complete Remissions of Adult T-cell Leukemia with Anti-CD25 Recombinant Immunotoxin LMB-2 and Chemotherapy to Block Immunogenicity

scientific article published on 8 September 2015

Construction and preclinical evaluation of an anti-CD19 chimeric antigen receptor

scientific article published on September 2009

Controlled trial of dexverapamil, a modulator of multidrug resistance, in lymphomas refractory to EPOCH chemotherapy ⬇️

scientific article published on 01 August 1995

Cracking the diverse biologic code of diffuse large B-cell lymphoma

scientific article published on 21 January 2015

Cutaneous lymphomatoid granulomatosis: correlation of clinical and biologic features

scientific article published on 01 September 2001

Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling

scientific article published on 25 August 2005

DOCK 8 Deficiency, EBV+ Lymphomatoid Granulomatosis, and Intrafamilial Variation in Presentation.

scientific article published on 28 February 2017

Decitabine in Older Adults With Acute Myeloid Leukemia: Why Was the Dream Broken? ⬇️

scientific article published on May 10, 2013

Decoding the DNA Methylome of Mantle Cell Lymphoma in the Light of the Entire B Cell Lineage.

scientific article published on November 2016

Decreased mitochondrial apoptotic priming underlies stroma-mediated treatment resistance in chronic lymphocytic leukemia ⬇️

scientific article published on September 5, 2012

Detection and outcome of occult leptomeningeal disease in diffuse large B-cell lymphoma and Burkitt lymphoma.

scientific article

Detection of malignant hematopoietic cells in cerebral spinal fluid previously diagnosed as atypical or suspicious

scientific article published on 01 June 2006

Development of Hepatic Steatosis After Chemotherapy for Non-Hodgkin Lymphoma

scientific article published on 28 December 2018

Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment

scientific article

Differential Role of BCL2 in Molecular Subtypes of Diffuse Large B-cell Lymphoma ⬇️

scientific article published on December 15, 2011

Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma

scientific article

Diffuse large B cell lymphoma: molecular targeted therapy ⬇️

scientific article published on October 20, 2012

Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction

scientific article published on 26 July 2005

Diffuse large B-cell lymphoma-treatment approaches in the molecular era.

scientific article

Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303

scientific article published on 02 April 2019

Dose-Adjusted EPOCH-Rituximab Combined With Fludarabine Provides an Effective Bridge to Reduced-Intensity Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Lymphoid Malignancies ⬇️

scientific article published on February 6, 2012

Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy

scientific article

Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study

scientific article published on 01 December 2018

Dose-adjusted EPOCH-R therapy in MYC-rearranged diffuse large B-cell lymphoma: not yet the standard of care - Authors' reply

scientific article published on 01 March 2019

Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma

scientific article

Drug resistance in adult lymphomas

scientific article published on January 1994

Drug resistance in diffuse large B-cell lymphoma

scientific article published on October 2006

Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction

scientific article published on 04 July 2019

Dynamic monitoring of circulating tumor DNA in non-Hodgkin lymphoma.

scientific article published on 14 April 2016

EBV-associated lymphomas in adults

scientific article

EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma ⬇️

scientific article published on August 1, 1993

Efficacy of reduced-intensity allogeneic stem cell transplantation in chemotherapy-refractory non-hodgkin lymphoma

scientific article published in August 2005

Egress of CD19(+)CD5(+) cells into peripheral blood following treatment with the Bruton tyrosine kinase inhibitor ibrutinib in mantle cell lymphoma patients

scientific article

Elevated interleukin-10: a new cause of dyslipidemia leading to severe HDL deficiency

scientific article

Elevated serum-soluble interleukin-2 receptor levels in patients with anaplastic large cell lymphoma

scientific article

Emerging therapeutic paradigms to target the dysregulated Janus kinase/signal transducer and activator of transcription pathway in hematological malignancies

scientific article

End-of-treatment and serial PET imaging has prognostic value and clinical utility in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R - Response to Adams et al

scientific article published on 01 August 2018

End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision making

scientific article published on 10 May 2018

Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19 ⬇️

scientific article published on July 28, 2010

Establishment of early donor engraftment after reduced-intensity allogeneic hematopoietic stem cell transplantation to potentiate the graft-versus-lymphoma effect against refractory lymphomas

scientific article published in March 2003

Expanding the Precision Medicine Toolkit With Circulating Tumor DNA

scientific article published on 01 September 2020

Expression of the multidrug resistance-associated protein gene in refractory lymphoma: quantitation by a validated polymerase chain reaction assay

scientific article published on 01 May 1997

Extraoular muscle palsies in subcutaneous panniculitis-like T-cell lymphoma

scientific article published on 01 August 2003

FDG-PET lymphoma demonstration project invitational workshop

scientific article published on 01 March 2007

Female fertility following dose-adjusted EPOCH-R chemotherapy in primary mediastinal B-cell lymphomas

scientific article

Flow cytometric immunophenotypic profiles of mature gamma delta T-cell malignancies involving peripheral blood and bone marrow

scientific article

Flow cytometric immunophenotyping of cerebrospinal fluid

scientific article published on 01 July 2008

Fludarabine treatment of patients with chronic lymphocytic leukemia induces a p53-dependent gene expression response

scientific article

Fluorodeoxyglucose positron emission tomography (FDG-PET) for monitoring lymphadenopathy in the autoimmune lymphoproliferative syndrome (ALPS).

scientific article published in February 2006

Fluorodeoxyglucose positron emission tomography in the presence of cardiac metastases

scientific article

Focus on lymphomas

scientific article

Gene Expression Profiling of Mediastinal Gray Zone Lymphoma and Its Relationship to Primary Mediastinal B-cell Lymphoma and Classical Hodgkin Lymphoma

scientific article published on 30 March 2020

Genetic polymorphism in MDR-1: a tool for examining allelic expression in normal cells, unselected and drug-selected cell lines, and human tumors ⬇️

scientific article published on March 1, 1998

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma

scientific article published in April 2018

Genetics of Diffuse Large B-Cell Lymphoma

article

Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma

scientific article published on 07 January 2019

Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma.

scientific article

Good outcome of AIDS-related Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL) with abbreviated cycles of EPOCH-rituximab

scientific article published on 17 June 2009

Gray zone lymphoma: better treated like hodgkin lymphoma or mediastinal large B-cell lymphoma?

scientific article published on September 2012

Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations.

scientific article

Harnessing Noxa demethylation to overcome Bortezomib resistance in mantle cell lymphoma

scientific article

High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology

scientific article published on 9 September 2004

High-dose continuous infusion beta-lactam antibiotics for the treatment of resistant Pseudomonas aeruginosa infections in immunocompromised patients

scientific article

Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology

scientific article published on 27 February 2003

Hybrid dosing of the cyclin-dependent kinase (CDK) inhibitor flavopiridol in relapsed/refractory mantle cell lymphoma and diffuse large B-cell lymphoma

scientific article published on 17 June 2019

Immunophenotypic features distinguishing familial chronic lymphocytic leukemia from sporadic chronic lymphocytic leukemia

scientific article published on July 2008

Implications of the Shifting Pathobiology of AIDS-Related Lymphoma ⬇️

scientific article published on July 26, 2013

Improved ZAP‐70 assay using two clones, multiple methods of analysis and clinical correlation ⬇️

scientific article published on April 6, 2011

Improved classification of leukemic B-cell lymphoproliferative disorders using a transcriptional and genetic classifier.

scientific article

Improved survival in chronic lymphocytic leukemia in the past decade: a population-based study including 11,179 patients diagnosed between 1973-2003 in Sweden

scientific article published on September 2009

Infection of mesothelial cells with human herpes virus 8 in human immunodeficiency virus-infected patients with Kaposi's sarcoma, Castleman's disease, and recurrent pleural effusions

scientific article published in February 2003

Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma

scientific article published on 10 May 2017

Inhibition of Bruton tyrosine kinase in patients with severe COVID-19

scientific article published on 05 June 2020

Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report

scientific article published in November 2001

International Central Nervous System and Ocular Lymphoma Workshop: recommendations for the future

scientific article published on June 2006

International consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia

scientific article published on 01 January 2007

Landscape of somatic mutations and clonal evolution in mantle cell lymphoma.

scientific article published on 21 October 2013

Lenalidomide-induced upregulation of CD80 on tumor cells correlates with T-cell activation, the rapid onset of a cytokine release syndrome and leukemic cell clearance in chronic lymphocytic leukemia

scientific article published on September 2009

Liquid biopsy in non-Hodgkin's lymphoma

scientific article published on 01 June 2019

Low-intensity therapy in adults with Burkitt's lymphoma.

scientific article

Lymphomatoid granulomatosis

scientific article

Lymphomatoid granulomatosis and other Epstein-Barr virus associated lymphoproliferative processes

scientific article

Lymphomatoid granulomatosis with involvement of the hard palate: a case report

scientific article published on October 2008

Lymphomatoid granulomatosis--a single institute experience: pathologic findings and clinical correlations

scientific article

Lymphomatoid granulomatosis: abnormalities of the brain at MR imaging

scientific article

Lymphomatoid granulomatosis: pathogenesis, pathology and clinical implications

scientific article published on January 1, 1997

MYC gene rearrangement in diffuse large B-cell lymphoma does not confer a worse prognosis following dose-adjusted EPOCH-R.

scientific article published on 22 June 2017

Magnesium Restores Activity to Peripheral Blood Cells in a Patient With Functionally Impaired Interleukin-2-Inducible T Cell Kinase

scientific article published on 27 August 2019

Management of heavy chain diseases: the challenges of biologic heterogeneity

Mantle cell lymphoma: report of the 2009 Mantle Cell Lymphoma Consortium Workshop

scientific article

Mantle cell lymphoma: report of the 2010 Mantle Cell Lymphoma Consortium Workshop

scientific article

Methodological comparison of two anti‐ZAP‐70 antibodies ⬇️

scientific article published on April 6, 2011

Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma

scientific article

Minimal residual hairy cell leukemia eradication with moxetumomab pasudotox: phase I results and long-term follow-up

scientific article published on 27 February 2018

Modulation of clinical drug resistance in a B cell lymphoma patient by the protein kinase inhibitor 7-hydroxystaurosporine: presentation of a novel therapeutic paradigm.

scientific article

Modulation of multidrug resistance by dexverapamil in EPOCH-refractory lymphomas.

scientific article published in January 1995

Molecular Classification and Treatment of Diffuse Large B-Cell Lymphoma and Primary Mediastinal B-Cell Lymphoma

scientific article published on 01 May 2020

Molecular diagnosis of Burkitt's lymphoma

scientific article published in June 2006

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

scientific article

Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features

scientific article published on 20 August 2012

Monitoring clinical outcomes in aggressive B-cell lymphoma: From imaging studies to circulating tumor DNA

scientific article published on 03 July 2018

Moving beyond rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone for diffuse large B-cell lymphoma

scientific article published on 07 March 2014

Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia

scholarly article by Robert J Kreitman et al published August 2018 in Leukemia

Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma

scientific article published on 26 May 2020

Mycosis fungoides and Sézary syndrome

scientific article

NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a unique case series

scientific article

Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity ⬇️

scientific article published on November 18, 2010

Neutropenia associated with rituximab therapy

scientific article published on January 1, 2011

New Strategies in Peripheral T-Cell Lymphoma: Understanding Tumor Biology and Developing Novel Therapies ⬇️

scientific article published on December 1, 2010

Nodal and extranodal plasmacytomas expressing immunoglobulin a: an indolent lymphoproliferative disorder with a low risk of clinical progression

scientific article

Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma.

scientific article published in May 2012

Non-Hodgkin's lymphoma in Job's syndrome: a case report and literature review

scientific article

Novel CD19 expression in a peripheral T cell lymphoma: A flow cytometry case report with morphologic correlation

scientific article

Novel agents for B-cell non-Hodgkin lymphoma: science and the promise

scientific article published on 11 February 2010

Novel disease targets and management approaches for diffuse large B-cell lymphoma

scientific article published on August 2010

Oropharyngeal shedding of Epstein-Barr virus in the absence of circulating B cells

scientific article published on August 2008

PD-1 Blockade in Mediastinal Gray-Zone Lymphoma.

scientific article published in July 2017

Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion.

scientific article

Pathobiology and Treatment of Lymphomatoid Granulomatosis; A Rare EBV-Driven Disorder

scientific article published on 27 February 2020

Pathogenic B-cell receptor signaling in lymphoid malignancies: New insights to improve treatment

scientific article published on 01 September 2019

Pathogenic role of B-cell receptor signaling and canonical NF-κB activation in mantle cell lymphoma

scientific article published on 28 April 2016

Persistent non-neoplastic gammadelta-T cells in cerebrospinal fluid of a patient with hepatosplenic (gammadelta) T cell lymphoma: a case report with 6 years of flow cytometry follow-up.

scientific article published on 15 October 2009

Phase 1/2 study of alemtuzumab with dose-adjusted EPOCH in untreated aggressive T and NK cell lymphomas

scientific article published on 10 January 2019

Phase I and pharmacokinetic study of the multidrug resistance modulator dexverapamil with EPOCH chemotherapy ⬇️

scientific article published on August 1, 1995

Phase I dose escalation study of the anti-CD2 monoclonal antibody, siplizumab, with DA-EPOCH-R in aggressive peripheral T-cell lymphomas.

scientific article published on 16 October 2017

Phase I trial of 7-hydroxystaurosporine and fludararbine phosphate: in vivo evidence of 7-hydroxystaurosporine induced apoptosis in chronic lymphocytic leukemia.

scientific article published on 12 July 2011

Phase I trial of anti-CD22 recombinant immunotoxin moxetumomab pasudotox (CAT-8015 or HA22) in patients with hairy cell leukemia

scientific article

Phase I trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with B-cell malignancies

scientific article published on 01 August 2005

Phase I trial of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) in patients with hematologic malignancies

scientific article published on April 2000

Phase II and dose-escalation with or without granulocyte colony-stimulating factor study of 9-aminocamptothecin in relapsed and refractory lymphomas ⬇️

scientific article published on July 1, 1998

Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers

scientific article

Phase II study of paclitaxel in relapsed non-Hodgkin's lymphomas

scientific article published on 01 February 1995

Phase II trial of dose-adjusted EPOCH in untreated systemic anaplastic large cell lymphoma

scientific article published on 30 October 2015

Phase II trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with hairy cell leukemia

scientific article published on 04 May 2009

Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival

scientific article published on 13 February 2007

Precision treatment of distinct molecular subtypes of diffuse large B-cell lymphoma: ascribing treatment based on the molecular phenotype

scientific article published on 01 October 2014

Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells

article

Primary intraocular lymphoma: current and future perspectives

scientific article published on 01 September 2006

Primary mediastinal B-cell lymphoma and mediastinal gray zone lymphoma: do they require a unique therapeutic approach?

scientific article

Primary mediastinal large B-cell lymphoma, classic Hodgkin lymphoma presenting in the mediastinum, and mediastinal gray zone lymphoma: what is the oncologist to do?

scientific article published in September 2011

Prognostic Value of Interim FDG-PET in Diffuse Large Cell Lymphoma: Results from the CALGB 50303 Clinical Trial

scientific article published on 13 March 2020

Progress in Chronic Lymphocytic Leukemia with Targeted Therapy.

scientific article published in January 2016

Prolonged half-life of voriconazole in a CYP2C19 homozygous poor metabolizer receiving vincristine chemotherapy: avoiding a serious adverse drug interaction

scientific article

Radiofrequency ablation of lymphoma

scientific article published on 27 October 2005

Randomized Phase II Study of First-Line Cladribine With Concurrent or Delayed Rituximab in Patients With Hairy Cell Leukemia

scientific article published on 28 February 2020

Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma.

scientific article

Rapid clearance of rituximab may contribute to the continued high incidence of autoimmune hematologic complications of chemoimmunotherapy for chronic lymphocytic leukemia ⬇️

scientific article published on May 28, 2013

Re: Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials

scientific article published on 17 August 2009

Recombinant immunotoxins and other therapies for relapsed/refractory hairy cell leukemia ⬇️

scientific article published on June 1, 2011

Recombinant immunotoxins for treating cancer

scientific article published on April 2004

Reevaluating the accelerated approval process for oncology drugs

scientific article published on 03 April 2013

Refining the treatment of follicular lymphoma

scientific article published on January 2008

Relationship of p53, bcl-2, and tumor proliferation to clinical drug resistance in non-Hodgkin's lymphomas

scientific article published on 01 January 1997

Reply to J. Wang et al

scientific article published on 12 February 2019

Reply to M. Hertzberg et al

scientific article published on 15 September 2020

Reply to M. Skelin et al

scientific article published on 07 August 2019

Reply to T.M. Weis et al

scientific article published on 18 September 2019

Reversal of Multidrug Resistance

scientific article published on 01 January 1994

Reversal of multidrug resistance.

scientific article

Rituximab treatment of refractory fludarabine-associated immune thrombocytopenia in chronic lymphocytic leukemia.

scientific article

Rituximab-associated neutropenia

scientific article published on April 2010

Role of a doxorubicin-containing regimen in relapsed and resistant lymphomas: an 8-year follow-up study of EPOCH.

scientific article

Role of molecular subtype in predicting outcome of AIDS-related diffuse large B-cell lymphoma

scientific article published on 26 April 2010

Role of the tumor microenvironment in mature B-cell lymphoid malignancies

scientific article

Safety and efficacy of navitoclax, a BCL-2 and BCL-XL inhibitor, in patients with relapsed or refractory lymphoid malignancies: results from a phase 2a study

scientific article published on 25 November 2020

Stromal gene signatures in large-B-cell lymphomas

scientific article

Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study.

scientific article published on 17 June 2008

T-cell lymphoma

scientific article published on 01 March 2013

Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma.

scientific article published on 20 July 2015

Targeting CD52 as a novel therapeutic strategy in angioimmunoblastic T-cell lymphoma ⬇️

scientific article published on 01 September 2010

Targeting HLA-DR.

scientific article published on December 2009

Targeting malignant B cells with an immunotoxin against ROR1

scientific article

The BCL-2 biomarker in the era of molecular diagnosis of diffuse large B-cell lymphoma

scientific article published on 01 June 2007

The Roleof MDR-1in Refractory Lymphoma ⬇️

scientific article published on December 1, 1997

The case for rituximab in AIDS-related lymphoma

scientific article published on 01 April 2006

The development of liquid biopsy for research and clinical practice in lymphomas: Report of the 15-ICML workshop on ctDNA

scientific article published on 30 December 2019

The effects of cardiovascular disease on the clinical outcome of elderly patients with diffuse large B-cell lymphoma

scientific article published on 15 July 2014

The landscape of new drugs in lymphoma

scientific article published on 29 December 2016

The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia ⬇️

scientific article published on October 12, 2010

The pharmacokinetics of rituximab following an intravitreal injection

scientific article published on 11 November 2005

The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

article

The role of Mig, the monokine induced by interferon-gamma, and IP-10, the interferon-gamma-inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative disease ⬇️

scientific article published on November 15, 1997

The role of rituximab and chemotherapy in aggressive B-cell lymphoma: a preliminary report of dose-adjusted EPOCH-R.

scientific article published in February 2002

The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma

scientific article

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

scientific article

The value of positron emission tomography in prognosis and response assessment in non-Hodgkin lymphoma

scientific article published on August 2010

Therapy in Primary Mediastinal B-Cell Lymphoma ⬇️

scientific article published on July 18, 2013

Transfusion medicine illustrated. Hemophagocytosis and coagulopathy associated with cutaneous gamma-delta T-cell lymphoma

scientific article published on 01 December 2004

Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients.

scientific article published on 06 September 2013

Treatment strategies for aggressive lymphomas: what works?

scientific article published on January 2013

Treatment-induced oxidative stress and cellular antioxidant capacity determine response to bortezomib in mantle cell lymphoma

scientific article

Unique cell surface expression of receptor tyrosine kinase ROR1 in human B-cell chronic lymphocytic leukemia.

scientific article

Update on Burkitt Lymphoma

scientific article published on December 2016

Update on the Pathogenesis, Diagnosis, and Therapy of AIDS-related Lymphoma

scientific article published on 01 April 2003

Using biologic predictive factors to direct therapy of diffuse large B-cell lymphoma ⬇️

scientific article published on February 1, 2013

Utilization of polymerase chain reaction on archival cytologic material: a comparison with fresh material with special emphasis on cerebrospinal fluids

scientific article published on October 2004

Vaccine-induced tumor-specific immunity despite severe B-cell depletion in mantle cell lymphoma

scientific article published on 21 August 2005

Variable CD52 expression in mature T cell and NK cell malignancies: implications for alemtuzumab therapy

scientific article

Viral, immunologic, and clinical features of primary effusion lymphoma

scientific article published on 19 February 2019

What is the standard of care for primary mediastinal b-cell lymphoma; R-CHOP or DA-EPOCH-R?

scientific article published on 13 March 2018

ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile

scientific article published on 20 February 2003

microRNA expression profiles identify subtypes of mantle cell lymphoma with different clinicobiological characteristics

scientific article published on 02 May 2013

Paulina is supported by:

About Paulina

Help